Clinical and population sciences added value of blinded outcome adjudication committee in an open-label randomized trial background and purpose: blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging

HIGHLIGHTS

• who: Stroke et al. from the Departments of Neurology (NA.M.v.d.E., B.R., O.A.B., P.J.K., D.W.J.D.), Radiology and Nuclear Medicine (N.A.M.v.d.E., B.R., O.A.B., A.v.d.L.), and Public Health (H.F.L.), Erasmus MC University Medical Center, Rotterdam, the Netherlands. Departments of Radiology and Nuclear Medicine (O.A.B., C.B.L.M.M.) and Neurology (O.A.B., Y.B.W.E.M.R.), Amsterdam UMC, University of Amsterdam, the Netherlands. Department of Neurology, Haaglanden Medical Center . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.